840,000 Shares
WINSTAR COMMUNICATIONS, INC.
Common Stock ($0.01 par value)
INTERNATIONAL UNDERWRITING AGREEMENT
January [o], 1999
TO: SALOMON BROTHERS INTERNATIONAL LIMITED
CREDIT SUISSE FIRST BOSTON (EUROPE) LIMITED
c/o: SALOMON BROTHERS INTERNATIONAL LIMITED ("SALOMON INTERNATIONAL")
▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇
Ladies and Gentlemen:
1. Introductory. WinStar Communications, Inc., a Delaware corporation
(the "Issuer" or "WinStar"), has agreed, subject to the terms and conditions
stated herein, to issue and sell (the "International Offering") to the several
international underwriters named in Schedule A hereto (the "International
Underwriters") an aggregate of 840,000 shares (the "International Securities")
of the Issuer's Common Stock, $0.01 par value per share ("Common Stock").
It is understood that the Issuer and WinStar Multichannel Corp.
("WMC") are concurrently entering into a U.S. Underwriting Agreement, dated the
date hereof (the "U.S. Underwriting Agreement"), with certain U.S. underwriters
listed in Schedule A thereto (the "U.S. Underwriters"), for whom ▇▇▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇ Inc. ("Salomon") and Credit Suisse First Boston Corporation are acting
as representatives (the "U.S. Representatives") relating to the concurrent
offering and sale of 3,360,000 shares (the "Firm Securities") of Common Stock
in the United States and Canada (the "U.S. Offering"). The Issuer also proposes
to grant to the U.S. Underwriters an option, exercisable by Salomon, for an
aggregate of not more than 630,000 additional shares (the
"Optional Securities"). The Firm Securities and the Optional Securities are
herein collectively called the "U.S. Offered Securities". The U.S. Offered
Securities and the International Securities are collectively referred to as the
"Offered Securities". The United States Securities Act of 1933 is herein
referred to as the "Securities Act". To provide for the coordination of their
activities, the U.S. Underwriters and the International Underwriters have
entered into an Agreement Between U.S. Underwriters and International
Underwriters which permits them, among other things, to sell the Offered
Securities to each other for purposes of resale.
The Issuer hereby agrees with the several International Underwriters
as follows:
2. Representations and Warranties of the Issuer. The Issuer represents
and warrants to, and agrees with, the several International Underwriters that:
3
(a) A registration statement on Form S-3 (No. 333-70263)
relating to the Offered Securities, including a form of prospectus
relating to the U.S. Offered Securities and a form of prospectus
relating to the International Securities, has been filed with the
Securities and Exchange Commission (the "Commission") and either (i)
has been declared effective under the Securities Act and is not
proposed to be amended or (ii) is proposed to be amended by amendment
or post-effective amendment. If such registration statement ("Initial
Registration Statement") has been declared effective, either (i) an
additional registration statement ("Additional Registration
Statement") relating to the Offered Securities may have been filed
with the Commission pursuant to Rule 462(b) ("Rule 462(b)") under the
Securities Act and, if so filed, has become effective upon filing
pursuant to such Rule and the Offered Securities all have been duly
registered under the Securities Act pursuant to the Initial
Registration Statement and, if applicable, the Additional Registration
Statement or (ii) such an Additional Registration Statement is
proposed to be filed with the Commission pursuant to Rule 462(b) and
will become effective upon filing pursuant to such Rule and upon such
filing the Offered Securities will all have been duly registered under
the Securities Act pursuant to the Initial Registration Statement and
such Additional Registration Statement. If the Issuer does not propose
to amend the Initial Registration Statement or if an Additional
Registration Statement has been filed and the Issuer does not propose
to amend it, and if any post-effective amendment to either such
registration statement has been filed with the Commission prior to the
execution and delivery of this Agreement, the most recent amendment
(if any) to each such registration statement has been declared
effective by the Commission or has become effective upon filing
pursuant to Rule 462(c) ("Rule 462(c)") under the Securities Act or,
in the case of the Additional Registration Statement, Rule 462(b). For
purposes of this Agreement, "Effective Time" with respect to the
Initial Registration Statement or, if filed prior to the execution and
delivery of this Agreement, the Additional Registration Statement
means (i) if the Issuer has advised Salomon International that it does
not propose to amend such registration statement, the date and time as
of which such registration statement, or the most recent
post-effective amendment thereto (if any) filed prior to the execution
and delivery of this Agreement, was declared effective by the
Commission or has become effective upon filing pursuant to Rule
462(c), or (ii) if the Issuer has advised Salomon International that it
proposes to file an amendment or post-effective amendment to such
registration statement, the date and time as of which such registration
statement, as amended by such amendment or post-effective amendment, as
the case may be, is declared effective by the Commission. If an
Additional Registration Statement has not been filed prior to the
execution and delivery of this Agreement but the Issuer has advised
Salomon International that it proposes to file one, "Effective Time"
with respect to such Additional Registration Statement means the date
and time as of which such registration statement is filed and becomes
effective pursuant to Rule 462(b). "Effective Date" with respect to
4
the Initial Registration Statement or the Additional Registration
Statement (if any) means the date of the Effective Time thereof. The
Initial Registration Statement, as amended at its Effective Time,
including (i) all information contained in the Additional Registration
Statement (if any) and deemed to be a part of the Initial Registration
Statement as of the Effective Time of the Additional Registration
Statement pursuant to the General Instructions of the Form on which it
is filed, (ii) all information (if any) deemed to be a part of the
Initial Registration Statement as of its Effective Time pursuant to
Rule 430A(b) ("Rule 430A(b)") under the Securities Act and (iii) all
other material incorporated by reference therein, is hereinafter
referred to as the "Initial Registration Statement". The Additional
Registration Statement, as amended at its Effective Time, including (i)
the contents of the Initial Registration Statement incorporated by
reference therein, (ii) all information (if any) deemed to be a part of
the Additional Registration Statement as of its Effective Time pursuant
to Rule 430A(b) and (iii) all other material incorporated by reference
therein, is hereinafter referred to as the "Additional Registration
Statement". The Initial Registration Statement and the Additional
Registration Statement are hereinafter referred to collectively as the
"Registration Statements" and individually as a "Registration
Statement". The form of prospectus relating to the U.S. Offered
Securities and the form of Prospectus relating to the International
Securities, each of which shall be deemed to include all material
incorporated by reference therein and as first filed with the
Commission pursuant to and in accordance with Rule 424(b) ("Rule
424(b)") under the Securities Act or (if no such filing is required) as
included in a Registration Statement, are hereinafter referred to as
the "U.S. Prospectus" and the "International Prospectus", respectively,
and collectively as the "Prospectuses". No document has been or will be
prepared or distributed in reliance on Rule 434 under the Securities
Act.
(b) If the Effective Time of the Initial Registration
Statement is prior to the execution and delivery of this Agreement:
(i) on the Effective Date of the Initial Registration Statement, the
Initial Registration Statement conformed in all respects to the
requirements of the Securities Act and the rules and regulations of
the Commission ("Rules and Regulations") and did not include any
untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements
therein not misleading, (ii) on the Effective Date of the Additional
Registration Statement (if any), each Registration Statement
conformed, or will conform, in all respects to the requirements of the
Securities Act and the Rules and Regulations and did not include, or
will not include, any untrue statement of a material fact and did not
omit, or will not omit, to state any material fact required to be
stated therein or necessary to make the statements therein not
misleading and (iii) on the date of this Agreement, the Initial
Registration Statement and, if the Effective Time of the Additional
Registration Statement is prior to the execution and delivery of this
Agreement,
5
the Additional Registration Statement each conforms, and at the time
of filing of each of the Prospectuses pursuant to Rule 424(b) or (if
no such filing is required) at the Effective Date of the Additional
Registration Statement in which the Prospectuses are included, each
Registration Statement and each of the Prospectuses will conform in
all respects to the requirements of the Securities Act and the Rules
and Regulations, and none of such documents includes, or will include,
any untrue statement of a material fact or omits, or will omit, to
state any material fact required to be stated therein or necessary to
make the statements therein not misleading. If the Effective Time of
the Initial Registration Statement is subsequent to the execution and
delivery of this Agreement: on the Effective Date of the Initial
Registration Statement, the Initial Registration Statement and each of
the Prospectuses will conform in all respects to the requirements of
the Securities Act and the Rules and Regulations, none of such
documents will include any untrue statement of a material fact or will
omit to state any material fact required to be stated therein or
necessary to make the statements therein not misleading, and no
Additional Registration Statement has been or will be filed. The two
preceding sentences do not apply to statements in or omissions from a
Registration Statement or either of the Prospectuses based upon
written information furnished to the Issuer by any International
Underwriter through Salomon International or by any U.S. Underwriter
through the U.S. Representatives specifically for use therein, it
being understood and agreed that the only such information is that
described as such in Section 7(b) hereof. The Issuer's Annual Report
on Form 10-K most recently filed with the Commission and all
subsequent reports (collectively, the "Exchange Act Reports") which
have been filed by WinStar with the Commission or sent to stockholders
pursuant to the Securities Exchange Act of 1934 (the "Exchange Act"),
when they were filed with the Commission, conformed in all material
respects to the requirements of the Exchange Act and the Rules and
Regulations of the Commission thereunder.
(c) The Issuer has been duly incorporated and is an existing
corporation in good standing under the laws of the State of Delaware,
with corporate power and authority to own its properties and conduct
its business as described in each of the Prospectuses; and the Issuer
is duly qualified to do business as a foreign corporation in good
standing in all other jurisdictions in which its ownership or lease of
property or the conduct of its business requires such qualification,
except to the extent that the failure to be so qualified or be in good
standing would not have a material adverse effect on the condition
(financial or other), business, properties or results of operations of
the Issuer and its subsidiaries, taken as a whole (a "Material Adverse
Effect"). The Issuer is qualified to do business as a foreign
corporation in the State of New York.
(d) Each subsidiary of the Issuer has been duly incorporated
and is an existing corporation in good standing under the laws of the
jurisdiction of its
6
incorporation, with corporate power and authority to own its
properties and conduct its business as described in each of the
Prospectuses; and each subsidiary of the Issuer is duly qualified to
do business as a foreign corporation in good standing in all other
jurisdictions in which its ownership or lease of property or the
conduct of its business requires such qualification, except to the
extent that the failure to be so qualified or be in good standing
would not have a Material Adverse Effect; all of the issued and
outstanding capital stock of each subsidiary of the Issuer has been
duly authorized and validly issued and is fully paid and
nonassessable; and the capital stock of each subsidiary owned by the
Issuer, directly or through subsidiaries, is owned free from liens,
encumbrances and defects.
(e) The Offered Securities and all other outstanding shares
of capital stock of the Issuer have been duly authorized; all
outstanding shares of capital stock of the Issuer are, and, when the
Offered Securities have been delivered and paid for in accordance with
this Agreement and the U.S. Underwriting Agreement on each Closing
Date (as defined below), such Offered Securities will have been
validly issued, fully paid and nonassessable and will conform in all
material respects to the description thereof contained in the
Prospectuses; and the stockholders of the Issuer have no preemptive
rights with respect to the Offered Securities.
(f) Except as contemplated by this Agreement or as disclosed
in the Prospectuses, there are no contracts, agreements or
understandings between the Issuer and any person that would give rise
to a valid claim against the Issuer or any International Underwriter
or U.S. Underwriter for a brokerage commission, finder's fee or other
like payment in connection with the transactions contemplated by this
Agreement.
(g) Except as disclosed in the Prospectuses or in the
schedule previously provided to you, there are no contracts,
agreements or understandings between the Issuer and any person
granting such person the right to require the Issuer to file a
registration statement under the Securities Act with respect to any
securities of the Issuer owned or to be owned by such person or to
require the Issuer to include such securities in the securities
registered pursuant to a Registration Statement or in any securities
being registered pursuant to any other registration statement filed by
the Issuer under the Securities Act.
(h) The Offered Securities have been approved for listing on
The Nasdaq National Market.
(i) No consent, approval, authorization, or order of, or
filing with, any governmental agency or body or any court is required
for the consummation of the transactions contemplated by this
Agreement or the U.S. Underwriting Agreement
7
in connection with the issuance and sale of the Offered Securities by
the Issuer, other than as may be required under the Securities Act and
the Rules and Regulations of the Commission thereunder and such as may
be required by securities or blue sky laws of any state of the United
States or of any foreign jurisdiction in connection with the offer and
sale of the Offered Securities.
(j) The execution, delivery and performance of this Agreement
and the U.S. Underwriting Agreement, and the issuance and sale of the
Offered Securities will not result in a breach or violation of any of
the terms and provisions of, or constitute a default under, (i) any
statute, rule, regulation or order of any governmental agency or body
or any court, domestic or foreign, having jurisdiction over the Issuer
or any subsidiary of the Issuer or any of their properties, (ii) any
agreement or instrument to which the Issuer or any such subsidiary is
a party or by which the Issuer or any such subsidiary is bound or to
which any of the properties of the Issuer or any such subsidiary is
subject, or (iii) the charter or by-laws of the Issuer or any such
subsidiary, except, in the case of clause (i) or (ii), such breaches,
violations or defaults that individually or in the aggregate would not
have a Material Adverse Effect; and the Issuer has full corporate
power and authority to authorize, issue and sell the Offered
Securities to be sold by the Issuer as contemplated by this Agreement
and the U.S. Underwriting Agreement.
(k) This Agreement has been duly authorized, executed and
delivered by the Issuer and the U.S. Underwriting Agreement has been
duly authorized, executed and delivered by each of the Sellers (as
defined therein).
(l) Except as disclosed in the Prospectuses, the Issuer and
its subsidiaries have good and marketable title to all real properties
and all other properties and assets owned by them, in each case free
from liens, encumbrances and defects that would materially affect the
value thereof or materially interfere with the use made or to be made
thereof by them; and, except as disclosed in the Prospectuses, the
Issuer and its subsidiaries hold any leased real or personal property
under valid and enforceable leases with no exceptions that would
materially interfere with the use made or to be made thereof by them.
(m) The Issuer and its subsidiaries possess adequate
certificates, authorities or permits issued by appropriate
governmental agencies or bodies necessary to conduct the business now
operated by them and have not received any notice of proceedings
relating to the revocation or modification of any such certificate,
authority or permit that, individually or in the aggregate, could
reasonably be expected to have a Material Adverse Effect.
8
(n) No labor dispute with the employees of the Issuer or any
of its subsidiaries exists or, to the knowledge of the Issuer, is
imminent that could reasonably be expected to have a Material Adverse
Effect.
(o) The Issuer and its subsidiaries own, possess or can
acquire on reasonable terms, adequate trademarks, trade names and
other rights to inventions, know-how, patents, copyrights,
confidential information and other intellectual property
(collectively, "intellectual property rights") necessary to conduct
the business as now operated by them, or used in the conduct of the
business as now operated by them, except to the extent that the
failure to own or possess or the inability to acquire such
intellectual property rights would not individually or in the
aggregate have a Material Adverse Effect; and the Issuer has not
received any notice of infringement of or conflict with asserted
rights of others with respect to any intellectual property rights
that, if determined adversely to the Issuer or any of its
subsidiaries, would individually or in the aggregate have a Material
Adverse Effect.
(p) Except as disclosed in the Prospectuses, neither the
Issuer nor any of its subsidiaries is in violation of any statute,
rule, regulation, decision or order of any governmental agency or body
or any court, domestic or foreign, relating to the use, disposal or
release of hazardous or toxic substances or relating to the protection
or restoration of the environment or human exposure to hazardous or
toxic substances (collectively, "environmental laws"), owns or
operates any real property contaminated with any substance that is
subject to any environmental laws, is liable for any off-site disposal
or contamination pursuant to any environmental laws, or is subject to
any claim relating to any environmental laws, which violation,
contamination, liability or claim would individually or in the
aggregate have a Material Adverse Effect; and the Issuer is not aware
of any pending investigation which might lead to such a claim.
(q) Except as disclosed in the Prospectuses, there are no
pending actions, suits or proceedings against or affecting the Issuer,
any of its subsidiaries or any of their respective properties that,
individually or in the aggregate, could reasonably be expected to have
a Material Adverse Effect, or to materially and adversely affect the
ability of the Issuer to perform its obligations under this Agreement
or the U.S. Underwriting Agreement, or which are otherwise material in
the context of the sale of the Offered Securities; and, to the
Issuer's knowledge, no such actions, suits or proceedings are
threatened or contemplated.
(r) The financial statements included in each Registration
Statement and the Prospectuses present fairly the financial position
of the Issuer and its consolidated subsidiaries as of the dates shown
and their results of operations and cash flows for the periods shown,
such financial statements have been prepared in
9
conformity with the generally accepted accounting principles in the
United States applied on a consistent basis, the schedules included in
each Registration Statement present fairly the information required to
be stated therein, the assumptions used in preparing the pro forma
financial statements included in each Registration Statement and the
Prospectuses provide a reasonable basis for presenting the significant
effects directly attributable to the transactions or events described
therein, the related pro forma adjustments give appropriate effect to
those assumptions, and the pro forma columns therein reflect the
proper application of those adjustments to the corresponding
historical financial statement amounts.
(s) Except as disclosed in the Prospectuses, since the date
of the latest audited financial statements included in the
Prospectuses, there has been no material adverse change, nor any
development or event involving a prospective material adverse change,
in the condition (financial or other), business, properties or results
of operations of the Issuer and its subsidiaries taken as a whole (it
being understood that a change in the price of the Common Stock or the
continuation of operating losses consistent with the Issuer's
historical results shall be deemed not to be, in and of themselves,
such a material adverse change), and, except as disclosed in or
contemplated by the Prospectuses, there has been no dividend or
distribution of any kind declared, paid or made by the Issuer on any
class of its capital stock.
(t) The Issuer is not an open-end investment company, unit
investment trust or face-amount certificate company that is or is
required to be registered under Section 8 of the United States
Investment Company Act of 1940 (the "Investment Company Act"), nor is
it a closed-end investment company required to be registered, but not
registered, thereunder; and the Issuer is not and, after giving effect
to the offering and sale of the Offered Securities and the application
of the proceeds thereof as described in the Prospectuses, will not be
an "investment company" as defined in the Investment Company Act.
(u) The Issuer is subject to Section 13 or 15(d) of the
Exchange Act.
(v) The Issuer and its subsidiaries are in compliance in all
material respects with the Communications Act of 1934 (as amended by
the Telecommunications Act of 1996, the "Communications Act") and with
all applicable rules, regulations and policies of the Federal
Communications Commission (the "FCC").
(w) The Issuer has provided to the International Underwriters
a complete and accurate list of all licenses granted to the Issuer and
its subsidiaries [(other than experimental licenses in the 38 GHz
portions of the radio spectrum and
10
licenses granted to the Issuer or its subsidiaries or acquired from
Local Area Telecommunications, Inc. that are not in the 38 GHz portion
of the radio spectrum)] by the FCC (the "Licenses"). All of the
Licenses are currently valid and in full force and effect. Neither the
Issuer nor any of its subsidiaries has any knowledge of any
investigation, notice of apparent liability, violation, forfeiture or
other order or complaint issued by or before any court or regulatory
body, including the FCC, or of any other proceedings (other than
proceedings relating to the wireless communications industries
generally) which could in any manner materially threaten or adversely
affect the validity or continued effectiveness of any of the Licenses,
except that (A) on March 9, 1998, several parties filed petitions for
reconsideration (the "Petitions") of the 38 GHz Order (as defined in
the Prospectuses) alleging, among other things, that the February 10,
1998 License grants to the Issuer of additional channels in each of
Atlanta, Buffalo, Cincinnati, Dallas, Houston, Miami, New York, St.
Louis, Seattle, Spokane and Tampa were in violation of the rules of
the FCC and (B) on December 31, 1998, two parties filed petitions for
clarification and reconsideration of two December 1, 1998 License
correction grants to the Issuer in Atlanta and Dallas alleging that
such grants were in violation of the rules of the FCC.
(x) No event has occurred which (i) results in, or after
notice or lapse of time or both would result in, revocation,
suspension, adverse modification, nonrenewal, impairment, restriction
or termination of, or order of forfeiture with respect to, any License
or (ii) materially and adversely affects or could reasonably be
expected in the future to materially adversely affect any of the
rights of the Issuer or any of its subsidiaries thereunder.
(y) The Issuer and its subsidiaries have duly filed in a
timely manner all material filings, reports, applications, documents,
instruments and information required to be filed by them under the
Communications Act, and all such filings are true, correct and
complete in all material respects.
(z) Neither the Issuer nor any of its subsidiaries has any
reason to believe that any of the Licenses will not be renewed in the
ordinary course.
3. Purchase, Sale and Delivery of Offered Securities. On the basis of
the representations, warranties and agreements herein contained, but subject to
the terms and conditions herein set forth, the Issuer agrees to sell to the
International Underwriters, and each International Underwriter agrees,
severally and not jointly, to purchase, at a purchase price of U.S. $[ o ] per
share, from the Issuer that number of International Securities (rounded up or
down, as determined by Salomon International in its discretion, in order to
avoid fractions) obtained by multiplying the number of International Securities
set forth opposite the name of the Issuer in Schedule B hereto by a fraction
the numerator of which is the number of International Securities set forth
opposite the name of such International
11
Underwriter in Schedule A hereto and the denominator of which is the total
number of International Securities.
The Issuer will deliver the International Securities to Salomon
International for the accounts of the International Underwriters, against
payment of the purchase price in U.S. dollars Federal (same day) funds by wire
transfer to accounts previously designated to Salomon by the Issuer at one or
more financial institutions acceptable to Salomon International at the office
of Cravath, Swaine & ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇▇▇, at
9:00 A.M., New York time, on February [o ], 1999, or at such other time not
later than seven full business days thereafter as Salomon International and the
Issuer determine, such time being herein referred to as the "Closing Date". For
purposes of Rule 15c6-1 under the Exchange Act, the First Closing Date (if
later than the otherwise applicable settlement date) shall be the settlement
date for payment of funds and delivery of securities for all the Offered
Securities sold pursuant to the offering. The certificates for the
International Securities so to be delivered will be in definitive form, in such
denominations and registered in such names as Salomon International requests
and will be made available for checking and packaging at the above office of
Cravath, Swaine & ▇▇▇▇▇ at least 24 hours prior to the First Closing Date.
The Issuer will pay to the International Underwriters as aggregate
compensation for their commitments hereunder and for their services in
connection with the purchase of the International Securities and the management
of the International Offering thereof, if the sale and delivery of the
International Securities to the International Underwriters provided herein is
consummated, an amount equal to U.S. $[ o ] per International Security
purchased, which may be divided among the International Underwriters in such
proportions as they may determine. Such payment will be made on the Closing
Date in the case of the International Securities by way of deduction by the
International Underwriters of said amount from the purchase price for the
International Securities referred to above.
4. Offering by International Underwriters. It is understood that the
several International Underwriters propose to offer the International
Securities for sale to the public as set forth in the International Prospectus.
In connection with the distribution of the International Securities,
the International Underwriters, through a stabilizing manager, may over-allot
or effect transactions on any exchange, in any over-the-counter market or
otherwise which stabilize or maintain the market prices of the International
Securities at levels other than those which might otherwise prevail, but in
such event and in relation thereto, the International Underwriters will act for
themselves and not as agents of the Issuer, and any loss resulting from
over-allotment and stabilization will be borne, and any profit arising
therefrom will be beneficially retained, by the International Underwriters.
Such stabilizing, if commenced, may be discontinued at any time.
12
5. Certain Agreements of the Issuer and the International
Underwriters. The Issuer and the several International Underwriters agree that:
(a) If the Effective Time of the Initial Registration Statement is
prior to the execution and delivery of this Agreement, the Issuer will file
each of the Prospectuses with the Commission pursuant to and in accordance with
subparagraph (1) (or, if applicable and if consented to by Salomon
International, subparagraph (4)) of Rule 424(b) not later than the earlier of
(i) the second business day following the execution and delivery of this
Agreement or (ii) the fifteenth business day after the Effective Date of the
Initial Registration Statement. The Issuer will advise Salomon International
promptly of any such filing pursuant to Rule 424(b). If the Effective Time of
the Initial Registration Statement is prior to the execution and delivery of
this Agreement and an Additional Registration Statement is necessary to
register a portion of the Offered Securities under the Securities Act but the
Effective Time thereof has not occurred as of such execution and delivery, the
Issuer will file the Additional Registration Statement or, if filed, will file
a post-effective amendment thereto with the Commission pursuant to and in
accordance with Rule 462(b) on or prior to 10:00 P.M., New York time, on the
date of this Agreement or, if earlier, on or prior to the time either
Prospectus is printed and distributed to any International Underwriter or U.S.
Underwriter, or will make such filing at such later date as shall have been
consented to by Salomon International.
(b) The Issuer will advise Salomon International promptly of any
proposal to amend or supplement the Initial Registration Statement, the
Additional Registration Statement (if any) and either of the Prospectuses and
will not effect such amendment or supplement without Salomon International's
prior consent (which consent shall not be unreasonably withheld); and the
Issuer will also advise Salomon International promptly of the effectiveness of
each Registration Statement (if its Effective Time is subsequent to the
execution and delivery of this Agreement) and of any amendment or supplement to
a Registration Statement or either of the Prospectuses and of the institution
by the Commission of any stop order proceedings in respect of a Registration
Statement and will use its best efforts to prevent the issuance of any such
stop order and to obtain as soon as possible its lifting, if issued.
(c) If, at any time when a prospectus relating to the Offered
Securities is required to be delivered under the Securities Act in connection
with sales by any U.S. Underwriter, International Underwriter or dealer, any
event occurs as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to
state any material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading, or if it is
necessary at any time to amend the Prospectus to comply with the Securities
Act, the Issuer will promptly notify Salomon International of such event and
will promptly prepare and file with the
13
Commission, at its own expense, an amendment or supplement which will correct
such statement or omission or an amendment which will effect such compliance.
Neither Salomon International's consent to, nor the International Underwriters'
delivery of, any such amendment or supplement shall constitute a waiver of any
of the conditions set forth in Section 6.
(d) As soon as practicable, but not later than the Availability Date
(as defined below), the Issuer will make generally available to its
securityholders an earnings statement covering a period of at least 12 months
beginning after the Effective Date of the Initial Registration Statement (or,
if later, the Effective Date of the Additional Registration Statement) which
will satisfy the provisions of Section 11(a) of the Securities Act. For the
purpose of the preceding sentence, "Availability Date" means the 45th day after
the end of the fourth fiscal quarter following the fiscal quarter that includes
such Effective Date, except that, if such fourth fiscal quarter is the last
quarter of the Issuer's fiscal year, "Availability Date" means the 90th day
after the end of such fourth fiscal quarter.
(e) The Issuer will furnish to the International Underwriters copies
of each Registration Statement (five of which will be signed and will include
all exhibits), each preliminary prospectus relating to the International
Securities, and, until completion of the distribution of the International
Securities as determined by Salomon International, the International Prospectus
and all amendments and supplements to such documents, in each case in such
quantities as Salomon International requests. The International Prospectus
shall be so furnished on or prior to 3:00 P.M., New York time, on the business
day following the later of the execution and delivery of this Agreement or the
Effective Time of the Initial Registration Statement. All other documents shall
be so furnished as soon as available. The Issuer will pay the expenses of
printing and distributing to the International Underwriters all such documents.
(f) No action has been or, prior to the completion of the distribution
of the Offered Securities, will be taken by the Issuer in any jurisdiction
outside the United States and Canada that would permit a public offering of the
Offered Securities, or possession or distribution of the International
Prospectus, or any amendment or supplement thereto, or any related preliminary
prospectus issued in connection with the offering of the Offered Securities, or
any other offering material, in any country or jurisdiction where action for
that purpose is required.
(g) During the period of five years after the Closing Date, the Issuer
will furnish to Salomon International and, upon request, to each of the other
International Underwriters, as soon as practicable after the end of each fiscal
year, a copy of the Issuer's annual report to stockholders for such year; and
the Issuer will furnish to Salomon International (i) as soon as available, a
copy of each report and any definitive proxy statement of the Issuer filed with
the Commission under the Exchange Act or
14
mailed to stockholders and (ii) from time to time, such other publicly
available information concerning the Issuer as Salomon International may
reasonably request.
(h) The Issuer will pay all expenses incident to the performance of
its obligations under this Agreement, for any filing fees and other expenses
(including fees and disbursements of counsel) incurred in connection with
qualification of the Offered Securities for sale under the laws of such
jurisdictions as Salomon International designates and the printing of memoranda
relating thereto, for any travel expenses of the Issuer's officers and
employees and any other expenses of the Issuer in connection with attending or
hosting meetings with prospective purchasers of the Offered Securities, for any
transfer taxes on the sale of the Offered Securities and for expenses incurred
in distributing preliminary prospectuses and the Prospectuses (including any
amendments and supplements thereto) to the International Underwriters.
(i) The Issuer agrees that no Common Stock other than the Offered
Securities will be included for sale with the Registration Statement.
(j) For a period of 90 days after the date hereof (the "Applicable
Period"), the Issuer and the Issuer's executive officers and directors will not
sell (except that the executive officers and directors may, with the consent of
the Underwriters (which consent shall not be unreasonably withheld), sell
securities out of their customary margin accounts), contract to sell, pledge or
otherwise dispose of, directly or indirectly, or (except pursuant to agreements
executed on or prior to the date hereof) arrange to have declared effective
during the Applicable Period a registration statement under the Securities Act
covering the sale by the Issuer or the Issuer's executive officers and
directors of (i) any shares of Common Stock of the Issuer or any other capital
stock of the Issuer, or (ii) any other securities which are convertible into,
or exercisable or exchangeable for, Common Stock or other capital stock of the
Issuer (collectively, "Derivative Securities"), without the prior written
consent of Salomon, which shall not be unreasonably withheld, except (A) with
respect to the Issuer (1) Common Stock or preferred stock issued or delivered
as payment of dividends on, or upon conversion, of any preferred stock of the
Issuer, (2) securities issued or delivered upon conversion, exchange or
exercise of any other securities (including notes and debentures) of the Issuer
outstanding on the date of the Prospectuses or which become outstanding after
the date hereof without violating this section 5(j), (3) capital stock, options
and other equity- based awards issued pursuant to benefit or incentive plans
maintained for the officers, directors or employees of, or persons providing
services to, the Issuer or its subsidiaries, or pursuant to the Issuer's
dividend reinvestment, 401(k), stock purchase or similar plans, (4) securities
issued in connection with, or in furtherance of, mergers, acquisitions of
assets or equity of others (including spectrum licenses and application
therefor and interests in entities with spectrum licenses and application
therefor) or similar transactions, (5) securities representing a minority
interest in the Issuer issued to a strategic investor who agrees not to resell
such securities during the Applicable Period or
15
(6) Common Stock, preferred stock, other capital stock or Derivative Securities
in a transaction not registered under the Securities Act, if the Issuer does
not arrange to have a registration statement covering the resale of any such
securities declared effective during the Applicable Period, and (B) with
respect to the Issuer's executive officers and directors, (i) securities
transferred by an executive officer or director in a private transaction where
the transferee receiving such securities agrees to be bound by this section
5(j), (ii) the transfer of no more than 70,000 securities per each of the four
inside directors or (iii) the transfer of no more than 25,000 securities per
each of the four independent directors.
(k) Each International Underwriter agrees that (i) it is not
purchasing any of the International Securities for the account of any U.S. or
Canadian Person, (ii) it has not offered or sold, and will not offer or sell,
directly or indirectly, any of the International Securities or distribute any
International Prospectus to any person in the United States or Canada, or to
any U.S. or Canadian Person and (iii) any dealer to whom it may sell any of the
International Securities will represent that it is not purchasing for the
account of any U.S. or Canadian Person and agree that it will not offer or
resell, directly or indirectly, any of the International Securities in the
United States or Canada, or to any U.S. or Canadian Person or to any other
dealer who does not so represent and agree; provided, however, that the
foregoing shall not restrict (A) purchases and sales between the International
Underwriters on the one hand and the U.S. Underwriters on the other hand
pursuant to the Agreement Between U.S. Underwriters and International
Underwriters, (B) stabilization transactions contemplated under the Agreement
Between U.S. Underwriters and International Underwriters, conducted through
Salomon (or through the Representatives and Salomon International) as part of
the distribution of the Offered Securities and (C) sales to or through (or
distributions of International Prospectuses or the related preliminary
prospectuses to) persons not U.S. or Canadian who are investment advisors, or
who otherwise exercise investment discretion, and who are purchasing for the
account of any U.S. or Canadian Person.
6. Conditions of the Obligations of the International Underwriters.
The obligations of the several International Underwriters to purchase and pay
for the International Securities on the First Closing Date will be subject to
the accuracy of the representations and warranties on the part of the Issuer
herein, to the accuracy of the certificates of officers of the Issuer delivered
pursuant to the provisions hereof, to the performance by the Issuer of its
obligations hereunder and to the following additional conditions precedent:
16
(a) The International Underwriters shall have received a letter, dated
the date of delivery thereof (which, if the Effective Time of the Initial
Registration Statement is prior to the execution and delivery of this
Agreement, shall be on or prior to the date of this Agreement or, if the
Effective Time of the Initial Registration Statement is subsequent to the
execution and delivery of this Agreement, shall be prior to the filing of the
amendment or post-effective amendment to the registration statement to be filed
shortly prior to such Effective Time), of ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ LLP, in the agreed
form.
(b) The International Underwriters shall have received a letter, dated
the date of delivery thereof (which, if the Effective Time of the Initial
Registration Statement is prior to the execution and delivery of this
Agreement, shall be on or prior to the date of this Agreement or, if the
Effective Time of the Initial Registration Statement is subsequent to the
execution and delivery of this Agreement, shall be prior to the filing of the
amendment or post-effective amendment to the registration statement to be filed
shortly prior to such Effective Time), of Ernst & Young LLP in the agreed form.
(c) If the Effective Time of the Initial Registration Statement is not
prior to the execution and delivery of this Agreement, such Effective Time
shall have occurred not later than 10:00 P.M., New York time, on the date of
this Agreement or such later date as shall have been consented to by Salomon
International. If the Effective Time of the Additional Registration Statement
(if any) is not prior to the execution and delivery of this Agreement, such
Effective Time shall have occurred not later than 10:00 P.M., New York time, on
the date of this Agreement or, if earlier, the time either Prospectus is
printed and distributed to any International Underwriter or U.S. Underwriter,
or shall have occurred at such later date as shall have been consented to by
Salomon International. If the Effective Time of the Initial Registration
Statement is prior to the execution and delivery of this Agreement, each of the
Prospectuses shall have been filed with the Commission in accordance with the
Rules and Regulations and Section 5(a) of this Agreement. Prior to such Closing
Date, no stop order suspending the effectiveness of a Registration Statement
shall have been issued and no proceedings for that purpose shall have been
instituted or, to the knowledge of the Issuer or the International
Underwriters, shall be contemplated by the Commission.
(d) Subsequent to the execution and delivery of this Agreement, there
shall not have occurred (i) a change in U.S. or international financial,
political or economic conditions or currency exchange rates or exchange
controls as would, in the reasonable judgment of Salomon International, be
likely to prejudice materially the success of the proposed issue, sale or
distribution of the International Securities, whether in the primary market or
in respect of dealings in the secondary market, or (ii) (A) any change, or any
development or event involving a prospective change, in the condition
(financial or other), business, properties or results of operations of the
Issuer or its subsidiaries which, in the reasonable judgment of Salomon
International, is material and adverse and makes it impractical or inadvisable
to proceed with completion of the offering or the sale of and
17
payment for the International Securities; (B) any downgrading in the rating of
any debt securities of the Issuer by any "nationally recognized statistical
rating organization" (as defined for purposes of Rule 436(g) under the
Securities Act), or any public announcement that any such organization has
under surveillance or review its rating of any debt securities of the Issuer
(other than an announcement with positive implications of a possible upgrading,
and no implication of a possible downgrading, of such rating); (C) any
suspension or limitation of trading in securities generally on the New York
Stock Exchange, or any setting of minimum prices for trading on such exchange,
or any suspension of trading of any securities of the Issuer on any exchange or
in the over-the-counter market; (D) any banking moratorium declared by U.S.
Federal or New York authorities; or (E) any outbreak or escalation of major
hostilities in which the United States is involved, any declaration of war by
Congress or any other substantial national or international calamity or
emergency if, in the reasonable judgment of Salomon International, the effect
of any such outbreak, escalation, declaration, calamity or emergency makes it
impractical or inadvisable to proceed with completion of the offering or sale
of and payment for the International Securities.
(e) The International Underwriters shall have received opinions, dated
the Closing Date, of ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ & ▇▇▇▇▇▇, counsel for the Issuer, and of
▇▇▇▇▇▇▇ ▇▇▇▇ & ▇▇▇▇▇▇▇▇▇, regulatory counsel for the Issuer, in the agreed
form.
(f) The International Underwriters shall have received from Cravath,
Swaine & ▇▇▇▇▇, counsel for the International Underwriters, such opinion or
opinions, dated the Closing Date, with respect to the incorporation of the
Issuer, the validity of the Offered Securities, the Registration Statements,
the Prospectuses and other related matters as the International Underwriters
may reasonably require, and the Issuer shall have furnished to such counsel
such documents as they reasonably request for the purpose of enabling them to
pass upon such matters.
(g) The International Underwriters shall have received a certificate,
dated the Closing Date, of the Chief Executive Officer or any Vice President
and a principal financial or accounting officer of the Issuer in which such
officers, to the best of their knowledge after reasonable investigation, shall
state that the representations and warranties of the Issuer in this Agreement
are true and correct, that the Issuer has complied with all agreements and
satisfied all conditions on its part to be performed or satisfied hereunder at
or prior to the Closing Date; no stop order suspending the effectiveness of any
Registration Statement has been issued and no proceedings for that purpose have
been instituted or are contemplated by the Commission; the Additional
Registration Statement (if any) satisfying the requirements of subparagraphs
(1) and (3) of Rule 462(b) was filed pursuant to Rule 462(b), including payment
of the applicable filing fee in accordance with Rule 111(a) or (b) under the
Securities Act, prior to the time either Prospectus was printed and distributed
to any International Underwriter or U.S. Underwriter; and, subsequent to the
respective dates of the most recent financial
18
statements in the Prospectuses, there has been no material adverse change, nor
any development or event involving a prospective material adverse change, in
the condition (financial or other), business, properties or results of
operations of the Issuer and its subsidiaries taken as a whole except as set
forth in or contemplated by the Prospectuses or as described in such
certificate (it being understood that a change in the price of the Common Stock
or the continuation of operating losses consistent with the Issuer's historical
results shall be deemed not to be, in and of themselves, such a material
adverse change), and, except as disclosed in or contemplated by the
Prospectuses, there has been no dividend or distribution of any kind declared,
paid or made by the Issuer on any class of its capital stock.
(h) The International Underwriters shall have received a letter, dated
the Closing Date, of ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ LLP which meets the requirements of
subsection (a) of this Section, except that the specified date referred to in
such subsection will be a date not more than three days prior to such Closing
Date for the purposes of this subsection.
(i) The International Underwriters shall have received a letter, dated
the Closing Date, of Ernst & Young LLP which meets the requirements of
subsection (b) of this Section, except that the specified dated referred to in
such subsection will be a date not more than three business days prior to such
Closing Date for the purposes of this subsection.
(j) On such Closing Date, the U.S. Underwriters shall have purchased
the Firm Securities or the U.S. Optional Securities, as the case may be,
pursuant to the U.S. Underwriting Agreement.
(k) The Issuer has filed an application and received approval for the
listing of the Offered Securities with the Nasdaq National Market and has paid
the required fee.
(l) Each executive officer and director of the Issuer shall have
furnished to Salomon International a letter substantially in the form of
Exhibit A hereto and addressed to the International Underwriters relating to
sales of shares of Common Stock or any securities convertible into or
exercisable or exchangeable for such Common Stock, and each such letter shall
be in full force and effect on the Closing Date.
Documents described as being "in the agreed form" are documents which are in
the forms which have been initialed for the purpose of identification by
Cravath, Swaine & ▇▇▇▇▇, copies of which are held by the Issuer and Salomon
International with such changes as Salomon International may approve. The
Issuer will furnish the International Underwriters with such conformed copies
of such opinions, certificates, letters and documents as the International
Underwriters reasonably request. Salomon International may in its sole
discretion waive on behalf of the International Underwriters compliance with
any conditions to the obligations of the International Underwriters hereunder.
19
7. Indemnification and Contribution. (a) The Issuer will indemnify and
hold harmless each International Underwriter against any losses, claims,
damages or liabilities, joint or several, to which such International
Underwriter may become subject, under the Securities Act or the Exchange Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon any breach or alleged breach
of any of the representations and warranties of the Issuer contained herein or
any untrue statement or alleged untrue statement of any material fact contained
in any Registration Statement, either of the Prospectuses, or any amendment or
supplement thereto, or any related preliminary prospectus, or arise out of or
are based upon the omission or alleged omission to state therein a material
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, and will reimburse
each International Underwriter for any legal or other expenses reasonably
incurred by each International Underwriter in connection with investigating or
defending any such loss, claim, damage, liability or action as such expenses
are incurred; provided, however, that the Issuer will not be liable in any such
case to the extent that any such loss, claim, damage or liability arises out of
or is based upon an untrue statement or alleged untrue statement in or omission
or alleged omission from any of such documents in reliance upon and in
conformity with written information furnished to the Issuer by such
International Underwriter through Salomon International specifically for use
therein, it being understood and agreed that the only such information consists
of the information described as such in subsection (b) below; provided further,
however, that with respect to any untrue statement or alleged untrue statement
in or omission or alleged omission from any preliminary prospectus, the
indemnity agreement contained in this subsection (a) shall not inure to the
benefit of any International Underwriter that sold the Offered Securities
concerned to the person asserting any such losses, claims, damages or
liabilities, to the extent that such sale was an initial resale by such
International Underwriter and any such loss, claim, damage or liability of such
International Underwriter results from the fact that there was not sent or
given to such person, at or prior to the written confirmation of the sale of
such Offered Securities to such person, a copy of the Registration Statement or
Prospectus if the Issuer had previously furnished copies thereof to such
International Underwriter and such Registration Statement or Prospectus
corrected such untrue statement or omission or alleged untrue statement or
omission.
(b) Each International Underwriter will severally and not jointly
indemnify and hold harmless the Issuer against any losses, claims, damages or
liabilities to which the Issuer may become subject, under the Securities Act or
the Exchange Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon any
untrue statement or alleged untrue statement of any material fact contained in
the Registration Statement, either of the Prospectuses, or any amendment or
supplement thereto, or any related preliminary offering prospectus, or arise
out of or are based upon the omission or the alleged omission to state therein
a material
20
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, in each case to the
extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was made in reliance upon and in
conformity with written information furnished to the Issuer by such
International Underwriter through Salomon International specifically for use
therein, and will reimburse any legal or other expenses reasonably incurred by
the Issuer in connection with investigating or defending any such loss, claim,
damage, liability or action as such expenses are incurred, it being understood
and agreed that the only such information furnished by any International
Underwriter consists of the following information in the International
Prospectus furnished on behalf of the International Underwriters: (i) on the
cover page, the table and the last paragraph at the bottom concerning the terms
of the International Offering by the International Underwriters and (ii) under
the caption "Underwriting", (A) the list of International Underwriters and
their respective participation in the International Offering, (B) the fourth
paragraph concerning the concession and reallowance figures, (C) the sixth
paragraph concerning agreements among the U.S. Underwriters and the
International Underwriters, (D) the eighth paragraph concerning
over-allotments, syndicate covering transactions, stabilizing transactions and
penalty bids and (E) the ninth paragraph concerning passive market making.
(c) Promptly after receipt by an indemnified party under this Section
of notice of the commencement of any action, such indemnified party will, if a
claim in respect thereof is to be made against the indemnifying party under
subsection (a) or (b) above, notify the indemnifying party of the commencement
thereof; but the omission so to notify the indemnifying party will not relieve
it from any liability which it may have to any indemnified party otherwise than
under subsection (a) or (b) above. In case any such action is brought against
any indemnified party and it notifies the indemnifying party of the
commencement thereof, the indemnifying party will be entitled to participate
therein and, to the extent that it may wish, jointly with any other
indemnifying party similarly notified, to assume the defense thereof, with
counsel reasonably satisfactory to such indemnified party (who shall not,
except with the consent of the indemnified party (which consent shall not be
unreasonably withheld), be counsel to the indemnifying party), and after notice
from the indemnifying party to such indemnified party of its election so to
assume the defense thereof, the indemnifying party will not be liable to such
indemnified party under this Section for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense
thereof except as set forth below. Notwithstanding the indemnifying party's
election to appoint counsel to represent the indemnified party in an action,
the indemnified party shall have the right to employ separate counsel
(including local counsel), and the indemnifying party shall bear the reasonable
fees, costs and expenses of such separate counsel, if (i) the use of counsel
chosen by the indemnifying party to represent the indemnified party would
present such counsel with a conflict of interest, (ii) the actual or potential
defendants in, or targets of, any such action include both the indemnified
party and the
21
indemnifying party and the indemnified party shall have reasonably concluded
that there may be legal defenses available to it and/or other indemnified
parties which are different from or additional to those available to the
indemnifying party, (iii) the indemnifying party shall not have employed
counsel satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after notice of the institution of such action
or (iv) the indemnifying party shall authorize the indemnified party to employ
separate counsel at the expense of the indemnifying party. No indemnifying
party shall, without the prior written consent of the indemnified party (which
consent shall not be unreasonably withheld), effect any settlement of any
pending or threatened action in respect of which any indemnified party is or
could have been a party and indemnity could have been sought hereunder by such
indemnified party unless such settlement includes an unconditional release of
such indemnified party from all liability on any claims that are the subject
matter of such action.
(d) If the indemnification provided for in this Section is unavailable
or insufficient to hold harmless an indemnified party under subsection (a) or
(b) above, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a result of the losses, claims, damages or
liabilities referred to in subsection (a) or (b) above (i) in such proportion
as is appropriate to reflect the relative benefits received by the Issuer on
the one hand and the International Underwriters on the other from the offering
of the International Securities or (ii) if the allocation provided by clause
(i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)
above but also the relative fault of the Issuer on the one hand and the
International Underwriters on the other in connection with the statements or
omissions which resulted in such losses, claims, damages or liabilities as well
as any other relevant equitable considerations. The relative benefits received
by the Issuer on the one hand and the International Underwriters on the other
shall be deemed to be in the same proportion as the total net proceeds from the
International Offering of the International Securities (before deducting
expenses) received by the Issuer bear to the total discounts and commissions
received by the International Underwriters from the Issuer under this
Agreement. The relative fault shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or
the omission or alleged omission to state a material fact relates to
information supplied by the Issuer or the International Underwriters and the
parties' relative intent, knowledge, access to information and opportunity to
correct or prevent such untrue statement or omission. The amount paid by an
indemnified party as a result of the losses, claims, damages or liabilities
referred to in the first sentence of this subsection (d) shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any action or claim which
is the subject of this subsection (d). Notwithstanding the provisions of this
subsection (d), no International Underwriter shall be required to contribute
any amount in excess of the amount by which the total price at which the
International Securities purchased by it were resold exceeds the amount of any
damages which such International
22
Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. The International
Underwriters' obligations in this subsection (d) to contribute are several in
proportion to their respective purchase obligations and not joint.
(e) The obligations of the Issuer under this Section shall be in
addition to any liability which the Issuer may otherwise have and shall extend,
upon the same terms and conditions, to each person, if any, who controls any
International Underwriter within the meaning of the Securities Act or the
Exchange Act; and the obligations of the International Underwriters under this
Section shall be in addition to any liability which the respective
International Underwriters may otherwise have and shall extend, upon the same
terms and conditions, to each person, if any, who controls the Issuer within
the meaning of the Securities Act or the Exchange Act.
8. Default of International Underwriters. If any International
Underwriter or International Underwriters default in their obligations to
purchase International Securities hereunder and the aggregate number of shares
of International Securities that such defaulting International Underwriter or
International Underwriters agreed but failed to purchase does not exceed 10% of
the total number of shares of International Securities, Salomon International
may make arrangements satisfactory to the Issuer for the purchase of such
International Securities by other persons, including any of the International
Underwriters, but if no such arrangements are made by the Closing Date, the
nondefaulting International Underwriters shall be obligated severally, in
proportion to their respective commitments hereunder, to purchase the
International Securities that such defaulting International Underwriters agreed
but failed to purchase. If any International Underwriter or International
Underwriters so default and the aggregate number of shares of International
Securities with respect to which such default or defaults occur exceeds 10% of
the number of shares of International Securities and arrangements satisfactory
to Salomon International and the Issuer, for the purchase of such International
Securities by other persons are not made within 36 hours after such default,
this Agreement will terminate without liability on the part of any
nondefaulting International Underwriter or the Issuer, except as provided in
Section 9. As used in this Agreement, the term "International Underwriter"
includes any person substituted for an International Underwriter under this
Section. Nothing herein will relieve a defaulting International Underwriter
from liability for its default.
9. Survival of Certain Representations and Obligations. The respective
indemnities, agreements, representations, warranties and other statements of
the Issuer or its officers or directors and of the several International
Underwriters set forth in or made pursuant to this Agreement will remain in
full force and effect, regardless of any investigation, or statement as to the
results thereof, made by or on behalf of any International Underwriter, the
Issuer or any of the Issuer's representatives, officers or directors or any
controlling person, and will survive delivery of and payment for the
23
International Securities. If for any reason the purchase of the Offered
Securities by the International Underwriter is not consummated, the Issuer
shall remain responsible for the expenses to be paid or reimbursed by them
pursuant to Section 5 (other than with respect to a defaulting International
Underwriter) and the respective obligations of the Issuer and the International
Underwriters pursuant to Section 7 shall remain in effect. If the purchase of
the International Securities by the International Underwriters is not
consummated for any reason other than solely because of the termination of this
Agreement pursuant to Section 8 or solely because of the occurrence of any
event specified in clause (C), (D) or (E) of Section 6(d)(ii), the Issuer will
reimburse the International Underwriters for all out-of-pocket expenses
(including fees and disbursements of counsel) reasonably incurred by them in
connection with the offering of the International Securities.
10. Notices. All communications hereunder will be in writing and, if
sent to the International Underwriters will be mailed, delivered or telecopied
and confirmed to the International Underwriters, c/o Salomon Brothers
International Limited, ▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇, Attention: Equities
Department or, if sent to the Issuer, will be mailed, delivered or
electronically transmitted and confirmed to it at ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇
▇▇▇▇▇, Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇; provided, however, that any notice to an
International Underwriter pursuant to Section 7 will be mailed, delivered or
telecopied and confirmed to such International Underwriter.
11. Successors. This Agreement will inure to the benefit of and be
binding upon the parties hereto and their respective successors and the
controlling persons referred to in Section 7, and no other person will have any
right or obligation hereunder.
12. Representation of International Underwriters. Salomon
International will act for the several International Underwriters in connection
with this financing, and any action taken under this Agreement by Salomon
International will be binding upon all the International Underwriters.
13. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all such
counterparts shall together constitute one and the same Agreement.
14. Applicable Law. This Agreement shall be governed by, and construed
in accordance with, the laws of the State of New York without regard to
principles of conflicts of laws.
Each of the parties hereby submits to the nonexclusive jurisdiction of
the Federal and state courts in the Borough of Manhattan in The City of New
York in any suit or proceeding arising out of or relating to this Agreement or
the transactions contemplated hereby.
24
If the foregoing is in accordance with the International Underwriters'
understanding of our agreement, kindly sign and return to us one of the
counterparts hereof, whereupon it will become a binding agreement among the
Issuer and the several International Underwriters in accordance with its terms.
Very truly yours,
WinStar Communications, Inc.
By.........................................
Name:
Title:
The foregoing International Underwriting
Agreement is hereby confirmed and accepted
as of the date first above written.
SALOMON BROTHERS INTERNATIONAL LIMITED
By....................................
Name:
Title:
Credit Suisse First Boston (Europe) Limited
Each by its duly authorized attorney-in-fact:
....................................
Name:
SCHEDULE A
Number of
International
Securities
International Underwriters to be Purchased
-------------------------- ---------------
Salomon Brothers International Limited...................
Credit Suisse First Boston (Europe) Limited............... ----------
Total..................................................... 840,000
==========
A-1
SCHEDULE B
Number of
International
Securities to be Sold
---------------------
WinStar Communications, Inc....................... 840,000
Total............................................. 840,000
=======
B-1
Exhibit A
[DATE]
[The undersigned executive officer or director]
WinStar Communications, Inc.
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ Inc.
Credit Suisse First Boston Corporation
As Representatives of the Several U.S. Underwriters
c/o ▇▇▇▇▇▇▇ ▇▇▇▇▇ Barney Inc.
▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇
Salomon Brothers International Limited
Credit Suisse First Boston (Europe) Limited
c/o Salomon Brothers International Limited
▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇
Dear Sirs:
As an inducement to the U.S. Underwriters and the International
Underwriters to execute, respectively, the U.S. Underwriting Agreement and the
International Underwriting Agreement (collectively, the "Underwriting
Agreements"), pursuant to which an offering will be made of the Common Stock,
$0.01 par value per share (the "Securities") of WinStar Communications, Inc.
(the "Issuer"), the undersigned hereby agrees that, for a period of 90 days
after the date of the Underwriting Agreements (the "Applicable Period") to
which you are or expect to become parties, the undersigned will not offer, sell
(except that the undersigned may, with the consent of ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ Inc.
(which consent shall not be unreasonably withheld), sell securities out of his
customary margin account), contract to sell, pledge or otherwise dispose of,
directly or indirectly, or (except pursuant to agreements executed on or prior
to the date hereof) arrange to have declared effective during the Applicable
Period a registration statement under the Securities Act covering the sale by
the undersigned of (a) any shares of Common Stock of the Issuer or any other
capital stock of the Issuer or (b) any other securities which are convertible
into, or exercisable or exchangeable for, Common Stock or other capital stock
of the Issuer (collectively, "Derivative Securities"), without the prior
written consent of ▇▇▇▇▇▇▇ ▇▇▇▇▇ Barney Inc. (which shall not be unreasonably
withheld), except that the foregoing restrictions shall not apply to (i)
securities transferred by the undersigned in a private transaction where the
transferee receiving such securities agrees to be bound, (ii) the transfer of
no more than 70,000 securities per each of the four inside directors or (iii)
the transfer of no more than 25,000 securities per each of the four independent
directors.
In furtherance of the foregoing, the Issuer and its transfer agent and
registrar are hereby authorized to decline to make any transfer of shares of
Securities if such transfer would constitute a violation or breach of this
Agreement.
This Agreement shall be binding on the undersigned and the respective
successors, heirs, personal representatives and assigns of the undersigned.
This Agreement shall lapse and become null and void if the public offering
shall not have occurred on or before the date that is 60 days after the date of
this Agreement.
Very truly yours,
B-2
